Zobrazeno 1 - 10
of 119
pro vyhledávání: '"HPTN 052"'
Autor:
Myron S. Cohen, Victor Akelo, Emily Shava, José Henrique Pilotto, Mulinda Nyirenda, Ravindre Panchia, Maganizo Chagomerana, Suwat Chariyalertsak, Mina C. Hosseinipour, Sheela Godbole, Sharlaa Badal-Faesen
Publikováno v:
International Journal of STD & AIDS. 32:1204-1211
Sexually transmitted infections (STIs) remain a public health concern because of their interaction(s) with HIV. In the HPTN 052 study, STIs were evaluated in both HIV-positive index cases and their HIV-negative partners at enrollment and at yearly fo
Autor:
Kathleen Kahn, Sheri A. Lippman, Rebecca West, Hannah H. Leslie, Ann Gottert, Audrey Pettifor, Francesc Xavier Gómez-Olivé, Rhian Twine
Publikováno v:
J Acquir Immune Defic Syndr
In 2011 the landmark HIV Prevention Trials Network (HPTN) 052 trial found that early initiation of antiretroviral treatment (ART) in persons living with HIV (PLHIV) reduced viral transmission to uninfected partners by 96%.1 Treatment as prevention (T
Autor:
McKaylee Robertson, Denis Nash
Publikováno v:
Current HIV/AIDS Reports. 16:304-313
Early diagnosis and treatment of HIV following seroconversion improves individual and population health. Using published data on pre-treatment CD4 cell counts, we benchmarked the level of immunodeficiency at HIV diagnosis and ART initiation in the
Autor:
Myron S, Cohen, Ying Q, Chen, Marybeth, McCauley, Theresa, Gamble, Mina C, Hosseinipour, Nagalingeswaran, Kumarasamy, James G, Hakim, Johnstone, Kumwenda, Beatriz, Grinsztejn, Jose H S, Pilotto, Sheela V, Godbole, Suwat, Chariyalertsak, Breno R, Santos, Kenneth H, Mayer, Irving F, Hoffman, Susan H, Eshleman, Estelle, Piwowar-Manning, Leslie, Cottle, Xinyi C, Zhang, Joseph, Makhema, Lisa A, Mills, Ravindre, Panchia, Sharlaa, Faesen, Joseph, Eron, Joel, Gallant, Diane, Havlir, Susan, Swindells, Vanessa, Elharrar, David, Burns, Taha E, Taha, Karin, Nielsen-Saines, David D, Celentano, Max, Essex, Sarah E, Hudelson, Andrew D, Redd, Thomas R, Fleming, Robert, Bollinger
Publikováno v:
The New England journal of medicine, vol 375, iss 9
BackgroundAn interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked infections caused by human immunodeficiency virus type 1 (HIV-1) in s
Autor:
Dean Soko, Tamara Walsky, Gerald Tegha, Mina C. Hosseinipour, Ying Q. Chen, Laeyendecker Oliver, Theresa Gamble, Ethan A. Wilson, Katherine Schlusser, Barbara Debevec, Estelle Piwowar-Manning, Johnstone Kumwenda, Marybeth McCauley, Susan H. Eshleman, Myron S. Cohen, Jessica M. Fogel
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 75:426-430
BACKGROUND Antiretroviral therapy (ART) can downregulate antibody responses to HIV infection. We evaluated the impact of early vs. delayed ART on the performance of HIV diagnostic and incidence assays. METHODS Samples were obtained from 207 participa
Publikováno v:
Annual review of medicine. 71
The HIV Prevention Trials Network 052 study (HPTN 052) was a clinical trial designed to determine whether early treatment for HIV infection prevented transmission of the virus in couples where one partner was infected with HIV and the other was not,
Autor:
Alison Rodger, Caroline A. Sabin
Publikováno v:
Current Opinion in HIV and AIDS. 11:487-491
Purpose of review Until recently, conflicting data led to discrepancies in guideline recommendation on 'when to start' antiretroviral therapy (ART) in asymptomatic HIV infection. This review focuses on evidence underpinning guidelines over the past d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Virginie Supervie, Romulus Breban
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes-JAIDS
Journal of Acquired Immune Deficiency Syndromes-JAIDS, 2018, 79 (4), pp.440--444. ⟨10.1097/QAI.0000000000001845⟩
Journal of Acquired Immune Deficiency Syndromes-JAIDS, 2018, 79 (4), pp.440--444. ⟨10.1097/QAI.0000000000001845⟩
International audience; Background: Before the completion of HPTN 052, PARTNER, and Opposites Attract studies, data were lacking to directly estimate HIV transmission risk under effective combined antiretroviral treatment (cART). Rather, estimates we
Autor:
Ken Ondenge, George Otieno, Isdora Odero, Victor Akelo, Deborah A. Gust, Phoebe Okola, Victor Mudhune, Jecinter Oruko
Publikováno v:
International journal of STDAIDS. 30(1)
We conducted an exploratory analysis of former HIV Prevention Trials Network 052 (HPTN 052) clinical trial participants in 2016 to assess their (1) satisfaction with the HPTN 052 clinical trial care and treatment, and reasons for joining the trial; a